Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
0.938
+0.048 (5.39%)
Dec 20, 2024, 4:00 PM EST - Market closed
Indaptus Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -14.89 | -15.42 | -14.32 | -7.71 | -3.58 | -2.57 |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 |
| Loss (Gain) From Sale of Assets | - | - | -0.02 | - | - | - |
| Stock-Based Compensation | 2.75 | 2.97 | 2.96 | 1.51 | 0.14 | 0.12 |
| Other Operating Activities | - | -0.43 | -0.11 | - | - | - |
| Change in Accounts Payable | -0.27 | -0.68 | -1.15 | -4.24 | 0.11 | 0.38 |
| Change in Other Net Operating Assets | 0.88 | 0.16 | -0.43 | -0.85 | 0 | -0.07 |
| Operating Cash Flow | -11.53 | -13.41 | -13.08 | -11.29 | -3.32 | -2.13 |
| Capital Expenditures | - | - | - | -0 | - | -0 |
| Sale of Property, Plant & Equipment | - | - | 0.17 | 0.45 | - | - |
| Investment in Securities | - | 17.14 | -16.6 | - | - | - |
| Investing Cash Flow | - | 17.14 | -16.43 | 0.45 | - | -0 |
| Issuance of Common Stock | 3.38 | - | - | 0.39 | - | - |
| Other Financing Activities | -0.43 | - | - | 47.95 | 1.16 | 0.25 |
| Financing Cash Flow | 2.95 | - | - | 48.34 | 1.16 | 0.25 |
| Net Cash Flow | -8.58 | 3.74 | -29.51 | 37.49 | -2.16 | -1.88 |
| Free Cash Flow | -11.53 | -13.41 | -13.08 | -11.29 | -3.32 | -2.13 |
| Free Cash Flow Per Share | -1.32 | -1.60 | -1.58 | -2.76 | -1.71 | -2.91 |
| Cash Income Tax Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Levered Free Cash Flow | -6.37 | -7.77 | -7.07 | -1.99 | -0.82 | - |
| Unlevered Free Cash Flow | -6.37 | -7.77 | -7.07 | -1.99 | -0.82 | - |
| Change in Net Working Capital | -0.5 | 0.5 | 0.71 | -1.33 | -1.28 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.